Frusemide-induced nephrocalcinosis in very low birth weight infants
- PMID: 3290820
- DOI: 10.1007/BF02389002
Frusemide-induced nephrocalcinosis in very low birth weight infants
Abstract
Three very low birth weight infants, treated with frusemide for broncho-pulmonary dysplasia are described. They all developed medullary nephrocalcinosis identifiable by real time ultrasound. The sonographic findings of diffuse medullary hyper-echogenicity appears to be specific for nephrocalcinosis.